Acadia Healthcare’s (ACHC) “Outperform” Rating Reiterated at Royal Bank of Canada

Royal Bank of Canada restated their outperform rating on shares of Acadia Healthcare (NASDAQ:ACHC) in a research note released on Friday,Benzinga reports. The firm currently has a $64.00 price objective on the stock.

Other research analysts have also issued reports about the stock. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a report on Monday, January 6th. TD Cowen reduced their target price on shares of Acadia Healthcare from $70.00 to $66.00 and set a “buy” rating on the stock in a report on Tuesday, January 7th. Barclays lowered their price target on shares of Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating for the company in a report on Friday, November 22nd. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $45.00 to $75.00 in a research note on Thursday, December 12th. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $52.00 target price on shares of Acadia Healthcare in a report on Tuesday, December 10th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Acadia Healthcare presently has an average rating of “Moderate Buy” and a consensus target price of $70.22.

Acadia Healthcare Price Performance

ACHC stock opened at $44.92 on Friday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The company’s fifty day moving average price is $40.54 and its 200-day moving average price is $57.89. Acadia Healthcare has a one year low of $36.50 and a one year high of $87.77. The company has a market capitalization of $4.17 billion, a PE ratio of 14.73, a price-to-earnings-growth ratio of 1.77 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.90 by $0.01. The business had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business’s revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.91 EPS. On average, equities analysts anticipate that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Investors Weigh In On Acadia Healthcare

A number of institutional investors and hedge funds have recently bought and sold shares of ACHC. GAMMA Investing LLC increased its holdings in Acadia Healthcare by 57.1% during the third quarter. GAMMA Investing LLC now owns 663 shares of the company’s stock valued at $42,000 after buying an additional 241 shares during the period. Point72 Asia Singapore Pte. Ltd. purchased a new position in shares of Acadia Healthcare in the 2nd quarter valued at $59,000. Covestor Ltd raised its position in shares of Acadia Healthcare by 834.4% in the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company’s stock worth $72,000 after acquiring an additional 1,018 shares in the last quarter. DekaBank Deutsche Girozentrale purchased a new stake in shares of Acadia Healthcare during the 3rd quarter worth $86,000. Finally, Assetmark Inc. grew its stake in Acadia Healthcare by 66.1% in the third quarter. Assetmark Inc. now owns 1,485 shares of the company’s stock valued at $94,000 after purchasing an additional 591 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.